The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.

NCT06354101 · clinicaltrials.gov ↗

WITHDRAWN

Status

NETWORK

Sponsor class

Stopped Terminated by sponsor before enrolling any patients into the study.

Conditions

Metabolic Health

Interventions

DRUG: Tirzepatide
DRUG: Semaglutide

Sponsor

CorEvitas

Collaborators

[object Object]